
Damascus – Frontline
Between the exorbitant cost of supportive medicines and the burden of travel and accommodation, cancer patients from Syria’s toiling and popular classes face a daily battle that goes beyond the illness itself. Amid economic collapse and plummeting purchasing power – with poverty reaching 90 per cent of Syrians according to World Bank figures – and with the state withdrawing from its social role and neglecting the public health system in favour of neoliberal policies, poor patients have been left to face their fate, while modern treatments remain the preserve of warlords and the rich.
With the diagnosis, the Syrian worker’s ordeal with the hell of expenses begins. Although the authority advertises that chemotherapy doses are provided free in public hospitals, the cost of supportive medicines and tests exposes this illusion. In Tartus, Amer, a former worker in an electrical workshop who has lung cancer, embodies the tragedy of the working class: he receives a free dose, but is forced to buy an accompanying drug costing around 1.4 million Syrian pounds (about $100), sometimes twice a month. Out of work and without any social security, he finds himself defenceless against the greed of the pharmaceutical market.
The ugliness of class inequality and the injustice of the geographical distribution of services are laid bare in the case of Mohammad, who has mouth cancer and comes from the Hama countryside. Systematic impoverishment and the prohibitive cost of transport to the city centres forced him to stay in his village, unable to continue treatment, facing his pain and the complications of the disease in silence. His mother summed up the brutality of this economic and political system in one crushing phrase: “Death costs less than treatment.”
The burden is not limited to medicine. It extends to advanced imaging tests (such as MRI and CT scans), now priced at hundreds of dollars, as well as the cost of transport and accommodation in Damascus, where services are concentrated. Modest hotel rooms cost between $30 and $120 a night – enough to wipe out the resources of low-income families.
The suffering of little Iman and her father illustrates this drain: a single trip from Latakia to Damascus for treatment consumes his entire monthly salary as a public employee (about $100), leaving him unable to secure the barest necessities for his family, in the absence of any compensation or free accommodation provided by the state for patients and their relatives.
The Ministry of Health records between 17,000 and 20,000 new cancer cases every year (led by breast and lung cancer), and around 1,100 cases among children, most of them blood cancers. Despite these figures, modern immunotherapies and targeted therapies are almost entirely absent from public centres, on the pretext of import difficulties and cost. These expensive drugs have been left to be sold on the private market – meaning that the right to life is monopolised by the bourgeoisie and those with money, while the working patient is condemned to postpone treatment or turn to unofficial sources.
This health tragedy confirms that access to decent treatment has become a class privilege under a system that has placed the interests of its elites and warlords above the lives of millions. This drain will only stop with the building of a free, public health system as part of a comprehensive social transformation that returns wealth and power to the hands of the producing masses.

